Raku Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 13, 2022
Share
Raku Co., Ltd reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 98.65 million compared to TWD 124.92 million a year ago. Revenue was TWD 98.65 million compared to TWD 124.92 million a year ago. Net loss was TWD 15.93 million compared to TWD 19.58 million a year ago. Basic loss per share was TWD 0.45 compared to TWD 0.54 a year ago.
For the nine months, sales was TWD 330.32 million compared to TWD 332.71 million a year ago. Revenue was TWD 330.32 million compared to TWD 332.71 million a year ago. Net loss was TWD 18.88 million compared to TWD 58.51 million a year ago. Basic loss per share was TWD 0.53 compared to TWD 1.85 a year ago.
Raku Co Ltd, formerly Kino Biotech Co., Ltd., is a Singapore-based company. The Company is an integrated bio-nutraceutical and cosmeceutical company. The Company is focused on product conceptualization, development, commercialization, brand marketing, sale and distribution of healthcare and beauty products. The Company provides healthcare and beauty products and services through brands, including Kinohimitsu, Activa and Xpertise. It has over two logistic and distribution centers in Malaysia and China. The Company provides products to China, Singapore, Malaysia, Vietnam, Thailand and Indonesia.
RAKU CO., LTD 
